PT999828E - PROCESS FOR THE PRODUCTION OF PREPARATIONS OF ACTIVE SUBSTANCE WITH CONTROLLED LIBERATION FROM A MATRIX - Google Patents

PROCESS FOR THE PRODUCTION OF PREPARATIONS OF ACTIVE SUBSTANCE WITH CONTROLLED LIBERATION FROM A MATRIX

Info

Publication number
PT999828E
PT999828E PT98943632T PT98943632T PT999828E PT 999828 E PT999828 E PT 999828E PT 98943632 T PT98943632 T PT 98943632T PT 98943632 T PT98943632 T PT 98943632T PT 999828 E PT999828 E PT 999828E
Authority
PT
Portugal
Prior art keywords
matrix
preparations
production
active substance
active ingredient
Prior art date
Application number
PT98943632T
Other languages
Portuguese (pt)
Inventor
Torsten Hoffmann
Klaus Liebold
Joachim Wolf
Heiko Schumacher
Original Assignee
Awd Pharma Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Awd Pharma Gmbh & Co Kg filed Critical Awd Pharma Gmbh & Co Kg
Publication of PT999828E publication Critical patent/PT999828E/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/275Nitriles; Isonitriles
    • A61K31/277Nitriles; Isonitriles having a ring, e.g. verapamil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1694Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

A process for preparing a controlled release composition with a controlled release matrix and containing a pharmaceutically active ingredient, which comprises granulating the active ingredient with a molten matrix material or with a matrix material while it is being melted and with optional additional inactive materials at a first elevated temperature, then cooling and screening the granulate, forming a fluidized bed of the resulting material at a second elevated temperature, and recovering the resulting product; and the product formed by the process.
PT98943632T 1997-07-10 1998-07-01 PROCESS FOR THE PRODUCTION OF PREPARATIONS OF ACTIVE SUBSTANCE WITH CONTROLLED LIBERATION FROM A MATRIX PT999828E (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19729487A DE19729487A1 (en) 1997-07-10 1997-07-10 Process for the preparation of active ingredient preparations with controlled release from a matrix

Publications (1)

Publication Number Publication Date
PT999828E true PT999828E (en) 2004-02-27

Family

ID=7835229

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98943632T PT999828E (en) 1997-07-10 1998-07-01 PROCESS FOR THE PRODUCTION OF PREPARATIONS OF ACTIVE SUBSTANCE WITH CONTROLLED LIBERATION FROM A MATRIX

Country Status (11)

Country Link
US (1) US6103264A (en)
EP (1) EP0999828B1 (en)
JP (1) JP2002511095A (en)
AT (1) ATE250410T1 (en)
AU (1) AU9151398A (en)
CA (1) CA2242552C (en)
DE (2) DE19729487A1 (en)
DK (1) DK0999828T3 (en)
ES (1) ES2207856T3 (en)
PT (1) PT999828E (en)
WO (1) WO1999002134A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1312058B1 (en) * 1999-04-09 2002-04-04 Pharmaplus S R L METHOD FOR MICRO-ENCAPSULATION OF MEDICATIONS.
DE10029201A1 (en) 2000-06-19 2001-12-20 Basf Ag Retarded release oral dosage form, obtained by granulating mixture containing active agent and polyvinyl acetate-polyvinyl pyrrolidone mixture below the melting temperature
MXPA06005913A (en) * 2003-12-04 2006-06-27 Pfizer Prod Inc Azithromycin multiparticulate dosage forms by liquid-based processes.
CA2547597A1 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate compositions with improved stability
US6984403B2 (en) * 2003-12-04 2006-01-10 Pfizer Inc. Azithromycin dosage forms with reduced side effects
CN1889931A (en) * 2003-12-04 2007-01-03 辉瑞产品公司 Spray-congeal process using an extruder for preparing multiparticulate azithromycin compositions containing preferably a poloxamer and a glyceride
WO2005053639A2 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Controlled release multiparticulates formed with dissolution enhancers
ES2308274T3 (en) * 2003-12-04 2008-12-01 Pfizer Products Inc. PROCEDURE FOR MANUFACTURING MULTIPARTICULATE PHARMACEUTICALS.
BRPI0417348A (en) * 2003-12-04 2007-03-13 Pfizer Prod Inc spray gelatinization process using an extruder for preparing multiparticulate crystalline drug compositions preferably containing a poloxamer and a glyceride
WO2005053652A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
US20060204613A1 (en) * 2005-02-18 2006-09-14 Castro Armando J Chewing gum containing flavor delivery systems
US20060286200A1 (en) * 2005-04-18 2006-12-21 Castro Armando J Confections containing flavor delivery systems
RU2007143556A (en) * 2005-04-25 2009-06-10 ТЕВА ФАРМАСЬЮТИКАЛЗ ЮЭсЭй, ИНК. (US) PROLONGED RELEASE COMPOSITIONS

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3080293A (en) * 1960-08-02 1963-03-05 Hoffmann La Roche Process of making pleasant-tasting niacinamide beadlets
DE1617593A1 (en) * 1965-10-12 1971-04-29 Leo Pharm Prod Ltd Method of making tablets or pills
JP2681373B2 (en) * 1988-07-18 1997-11-26 塩野義製薬株式会社 Method for manufacturing sustained-release preparation
WO1993007859A1 (en) * 1991-10-23 1993-04-29 Warner-Lambert Company Novel pharmaceutical pellets and process for their production
SE9200858L (en) * 1992-03-20 1993-09-21 Kabi Pharmacia Ab Method for producing delayed release pellets
NZ260408A (en) * 1993-05-10 1996-05-28 Euro Celtique Sa Controlled release preparation comprising tramadol
DK0654263T3 (en) * 1993-11-23 2002-04-29 Euro Celtique Sa Process for the preparation of a sustained release preparation
EP0672416A1 (en) * 1994-03-14 1995-09-20 Euro-Celtique S.A. Pharmaceutical composition comprising diamorphine

Also Published As

Publication number Publication date
WO1999002134A3 (en) 1999-05-14
ATE250410T1 (en) 2003-10-15
EP0999828B1 (en) 2003-09-24
CA2242552C (en) 2002-02-05
CA2242552A1 (en) 1999-01-10
WO1999002134A2 (en) 1999-01-21
EP0999828A2 (en) 2000-05-17
DE19729487A1 (en) 1999-01-14
DK0999828T3 (en) 2004-01-19
ES2207856T3 (en) 2004-06-01
AU9151398A (en) 1999-02-08
JP2002511095A (en) 2002-04-09
DE59809737D1 (en) 2003-10-30
US6103264A (en) 2000-08-15

Similar Documents

Publication Publication Date Title
PT999828E (en) PROCESS FOR THE PRODUCTION OF PREPARATIONS OF ACTIVE SUBSTANCE WITH CONTROLLED LIBERATION FROM A MATRIX
ES2086229T3 (en) PROCEDURE FOR OBTAINING DELAYED ACTION MEDICINAL PREPARATIONS.
UA26449C2 (en) SOLID PHARMACEUTICAL FORM FOR ORAL APPLICATION WITH SLOW RELEASE OF ACTIVE SUBSTANCE AND METHOD OF PRODUCTION (PRODUCTS)
ES2061179T3 (en) GRANULATED PREPARATIONS AND METHOD TO PRODUCE THEM.
ES2143089T3 (en) PROCEDURE FOR THE MANUFACTURE OF PILLS WITH COATING.
ID27474A (en) PROCESS OF MAKING GRANUL FERTILIZER COMPOUNDS
PT1230197E (en) PROCESS FOR MAKING COMPOUND FERTILIZER GRANULES
PT84604B (en) METHOD FOR PREPARING PILLS FROM PELETES
BR9507879A (en) Process of preparing pearls of an undefined active principle ketoprene pearls with extended release and pearls of active principle presenting an undefined crystallization point
ES2193979T3 (en) PROCEDURE FOR OBTAINING A GRANULATE FROM A FUSION.
AU4398000A (en) A process for the microencapsulation of medicaments
FR2748459B1 (en) PROCESS FOR PRODUCING LIGHTWEIGHT MATERIAL AND RESULTING PRODUCT, PARTICULARLY BIODEGRADABLE PACKAGING PRODUCT
UA30026A (en) A method for purification of admixtures and growing monocrystals of refractory materials